Vulvodynia
|
disease |
Female Urogenital Diseases and Pregnancy Complications
|
Disease or Syndrome
|
6
|
1
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Calcium pyrophosphate deposition disease
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
34
|
5
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Familial (FPAH)
|
disease |
|
Disease or Syndrome
|
1075
|
276
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Cardio-Renal Syndrome
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
21
|
|
0.010 |
None |
< 0.001 |
1 |
|
2018 |
2018 |
Axial spondyloarthritis
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
67
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Infantile Spasm
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
93
|
39
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
IgE-mediated food allergy
|
disease |
Immune System Diseases
|
Disease or Syndrome
|
126
|
16
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Anxiety
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1048
|
287
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Anxiety Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
840
|
163
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Behavior Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
77
|
4
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Morphine Dependence
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
44
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Cocaine Dependence
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
199
|
39
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Female sexual dysfunction
|
disease |
|
Mental or Behavioral Dysfunction
|
22
|
3
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Drug Dependence
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
248
|
31
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.050 |
None |
1.000 |
5 |
|
2018 |
2020 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.030 |
None |
1.000 |
3 |
|
2017 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.030 |
None |
1.000 |
3 |
|
2017 |
2019 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2018 |
Choroid Plexus Papilloma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
64
|
17
|
0.020 |
None |
1.000 |
2 |
|
2007 |
2017 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2018 |
melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3087
|
515
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4173
|
1142
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Choroid Plexus Carcinoma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
34
|
11
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Adamantinous Craniopharyngioma
|
disease |
Neoplasms
|
Neoplastic Process
|
48
|
6
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4081
|
1204
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |